SMART FOR LIFE, INC.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000121390024080709 Filed on September 20, 2024

Income Statement

Concept	2024 Q3	2023 Q4	2023

Balance Sheet

Concept	2024 Q3	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$188.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$1.243M
Prepaid Expenses
Receivables		$70.23K
Other Receivables
Total Short-Term Assets		$2.332M
YoY Change		-35.3%
LONG-TERM ASSETS
Property, Plant & Equipment		$100.5K
YoY Change		-79.15%
Goodwill		$3.045M
YoY Change		126.9%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$17.33M
YoY Change		15704.01%
Total Long-Term Assets		$17.33M
YoY Change		-32.16%
TOTAL ASSETS
Total Short-Term Assets		$2.332M
Total Long-Term Assets		$17.33M
Total Assets		$19.66M
YoY Change		-32.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$3.613M
YoY Change		-12.4%
Accrued Expenses		$3.718M
YoY Change		96.93%
Deferred Revenue		$464.7K
YoY Change		-29.89%
Short-Term Debt		$12.36M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$22.06M
YoY Change		45.65%
LONG-TERM LIABILITIES
Long-Term Debt		$12.36M
YoY Change		-11.31%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$3.991M
YoY Change		-75.61%
TOTAL LIABILITIES
Total Short-Term Liabilities		$22.06M
Total Long-Term Liabilities		$3.991M
Total Liabilities		$26.05M
YoY Change		-17.34%
SHAREHOLDERS EQUITY
Retained Earnings		-$67.70M
YoY Change		50.47%
Common Stock		$37.00
YoY Change		-98.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$6.387M
YoY Change
Total Liabilities & Shareholders Equity		$19.66M
YoY Change		-32.55%

Cashflow Statement

Concept	2024 Q3	2023 Q4	2023

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41290
CY2023	dei	Entity Registrant Name EntityRegistrantName	SMART FOR LIFE, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-5360128
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 505
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
CY2023	dei	City Area Code CityAreaCode	(786)
CY2023	dei	Local Phone Number LocalPhoneNumber	749-1221
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	SMFL
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6370000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7090728	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	RBSM LLP
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	188596	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70820	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70231	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	540072	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1242777	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2182351	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	148993	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	301037	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	348971	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	509696	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2331710	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3603976	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100539	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	219191	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11046767	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16287098	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3045000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5816100	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	57324	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	72441	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2015299	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2298381	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	1062588	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	849768	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17327517	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25542979	usd
CY2023Q4	us-gaap	Assets Assets	19659227	usd
CY2022Q4	us-gaap	Assets Assets	29146955	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3612578	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3255322	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3718070	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1647865	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	464721	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	675426	usd
CY2023Q4	smfl	Preferred Stock Dividends Payable PreferredStockDividendsPayable	450562	usd
CY2022Q4	smfl	Preferred Stock Dividends Payable PreferredStockDividendsPayable	600750	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	298644	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	250646	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	10616114	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	6383557	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2631078	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1382001	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22055908	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15143518	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1800158	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2098803	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1748686	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	13452171	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	441929	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	814445	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3990773	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16365419	usd
CY2023Q4	us-gaap	Liabilities Liabilities	26046681	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31508937	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7936508	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7936508	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	373526	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	373526	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77614	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77614	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	37	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61280662	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42630425	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67668156	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44992415	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6387454	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2361982	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19659227	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29146955	usd
CY2023	us-gaap	Revenues Revenues	8225792	usd
CY2022	us-gaap	Revenues Revenues	15902529	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	5135685	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10812009	usd
CY2023	us-gaap	Gross Profit GrossProfit	3090107	usd
CY2022	us-gaap	Gross Profit GrossProfit	5090520	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4258202	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5337925	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5561017	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6167637	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	2263405	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	2165198	usd
CY2023	smfl	Consulting Fees Related Parties ConsultingFeesRelatedParties	46686	usd
CY2022	smfl	Consulting Fees Related Parties ConsultingFeesRelatedParties	1471199	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5843501	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2273288	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1899542	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	20246099	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17041501	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-17155992	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11950981	usd
CY2023	us-gaap	Other Income OtherIncome	400397	usd
CY2022	us-gaap	Other Income OtherIncome	-474	usd
CY2022	us-gaap	Other Expenses OtherExpenses	702420	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	269828	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	161039	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4634839	usd
CY2022	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15689565	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3964614	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16231420	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21120606	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28182401	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1555135	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1795415	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22675741	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-29977816	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	600750	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22675741	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30578565	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136346	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9766	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-154.9
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2885.77
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-11.41
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-183.84
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-166.31
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3069.61
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6090444	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10668316	usd
CY2022	smfl	Stock Issued During Period Value Series A Warrants Issued In Connection With Initial Public Offering StockIssuedDuringPeriodValueSeriesAWarrantsIssuedInConnectionWithInitialPublicOffering	1910743	usd
CY2022	smfl	Stock Issued During Period Value Series B Warrants In Connection With Initial Public Offering StockIssuedDuringPeriodValueSeriesBWarrantsInConnectionWithInitialPublicOffering	159229	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	65624	usd
CY2022	smfl	Stock Issued During Period Value Common Stock Issued Upon Exercise Of Series B Warrants StockIssuedDuringPeriodValueCommonStockIssuedUponExerciseOfSeriesBWarrants	-144	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8165386	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4	usd
CY2022	smfl	Stock Issued During Period Value Common Stock Issued For Conversion Of Accounts Payable StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfAccountsPayable	147223	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	922375	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	10844960	usd
CY2022	smfl	Stock Issued Duringperiod Value Common Stock Issued Upon Conversion Of Promissory Note StockIssuedDuringperiodValueCommonStockIssuedUponConversionOfPromissoryNote	73727	usd
CY2022	smfl	Stock Issued During Period Value Stock Issued For Cash In Private Placement StockIssuedDuringPeriodValueStockIssuedForCashInPrivatePlacement	910000	usd
CY2022	smfl	Stock Issued During Period Value For Debt Forbearance StockIssuedDuringPeriodValueForDebtForbearance	30500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	245333	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	53676	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-29977816	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2361982	usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	7269531	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	797535	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6555258	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	9	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	207199	usd
CY2023	smfl	Stockissued During Period Value Conversion Of Accrued Board Fees StockissuedDuringPeriodValueConversionOfAccruedBoardFees	30000	usd
CY2023	smfl	Stock Issued During Period Value Conversion Of Accrued Compensation StockIssuedDuringPeriodValueConversionOfAccruedCompensation	1178341	usd
CY2023	smfl	Stock Issued During Period Value Stock Issued For Cash In Private Placement StockIssuedDuringPeriodValueStockIssuedForCashInPrivatePlacement	2151310	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	186634	usd
CY2023	smfl	Warrant Placement Fee WarrantPlacementFee	274452	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22675741	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6387454	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22675741	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-29977816	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	83826	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	46763	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1266191	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2698080	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2273345	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2111346	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	269828	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	161039	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	797535	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	54285	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5843501	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	207199	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	922262	usd
CY2023	smfl	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-92569	usd
CY2023	smfl	Noncash Finance Fees NoncashFinanceFees	-753933	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-36456	usd
CY2022	smfl	Interest Expense Associated With Warrants Issued With Debt InterestExpenseAssociatedWithWarrantsIssuedWithDebt	65624	usd
CY2022	smfl	Interest Expense Associated With Future Equity Agreements InterestExpenseAssociatedWithFutureEquityAgreements	10844743	usd
CY2023	smfl	Accretion Related To Right Of Use Asset AccretionRelatedToRightOfUseAsset	32435	usd
CY2022	smfl	Accretion Related To Right Of Use Asset AccretionRelatedToRightOfUseAsset	25177	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-386015	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	226594	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-939574	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-524200	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-152044	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-44170	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-15116	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	47771	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	396928	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1973391	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2556332	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	263632	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	494530	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	576632	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-210705	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	277134	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	980192	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	299910	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5848553	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9685871	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29720	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-3450	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3450	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3029720	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	888130	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1220274	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	12812008	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2151310	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	909873	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7269531	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2885527	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	9797275	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5873881	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10621431	usd
CY2023	smfl	Repayments On Notes Payable Of Discontinued Operations RepaymentsOnNotesPayableOfDiscontinuedOperations	130564	usd
CY2022	smfl	Repayments On Notes Payable Of Discontinued Operations RepaymentsOnNotesPayableOfDiscontinuedOperations	309484	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5969779	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12588241	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	117776	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-127350	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70820	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	198170	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188596	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70820	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	274747	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4112081	usd
CY2022	smfl	Stock Issued For Conversion Of Accounts Payable StockIssuedForConversionOfAccountsPayable	147223	usd
CY2023	smfl	Stock Issued For Conversion Of Convertible Notes And Interest StockIssuedForConversionOfConvertibleNotesAndInterest	6555258	usd
CY2022	smfl	Stock Issued For Conversion Of Convertible Notes And Interest StockIssuedForConversionOfConvertibleNotesAndInterest	8165385	usd
CY2023	smfl	Stock Issued For Conversion Of Accrued Dividends StockIssuedForConversionOfAccruedDividends	186634	usd
CY2023	smfl	Stock Issued For Conversion Of Series B Preferred Stock To Common Stock StockIssuedForConversionOfSeriesBPreferredStockToCommonStock	9	usd
CY2022	smfl	Noncash Equipment Financing Of Discontinued Operations NoncashEquipmentFinancingOfDiscontinuedOperations	181815000000	usd
CY2022	smfl	Debt Issued In Connection With Acquisition Of Ceautamed DebtIssuedInConnectionWithAcquisitionOfCeautamed	5600000	usd
CY2022	smfl	Debt Issuance Cost In Connection With Debt DebtIssuanceCostInConnectionWithDebt	8463	usd
CY2023	smfl	Equipment Transferred From Discontinued Operation EquipmentTransferredFromDiscontinuedOperation	57659	usd
CY2023	smfl	Conversion Of Accrued Compensation ConversionOfAccruedCompensation	1178341	usd
CY2023	smfl	Stock Issued For Conversion Of Accrued Board Fees StockIssuedForConversionOfAccruedBoardFees	30000	usd
CY2023	smfl	Conversion Of Notes Payable To Accued Expenses ConversionOfNotesPayableToAccuedExpenses	26471	usd
CY2023	smfl	Conversion Of Interest To Notes Payable ConversionOfInterestToNotesPayable	334950	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Note 1</b></span><b> — Description of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Smart for Life, Inc., formerly Bonne Santé Group, Inc. (“SMFL”), is a Nevada corporation which was originally formed in the State of Delaware on February 2, 2017 and converted to a Nevada corporation on April 10, 2023. Structured as a global holding company, it is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutraceutical and related products with an emphasis on health and wellness.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 8, 2018, SMFL acquired 51% of Millenium Natural Manufacturing Corp. and Millenium Natural Health Products, Inc. On October 8, 2019, SMFL entered into an agreement to acquire the remaining 49% of these companies, subject to certain conditions which were subsequently met. On September 30, 2020, the name of Millenium Natural Manufacturing Corp. was changed to Bonne Sante Natural Manufacturing, Inc. (“BSNM”), and on November 24, 2020, Millenium Natural Health Products Inc. was merged into BSNM. Based in Doral, Florida, BSNM operates a 22,000 square-foot FDA-certified manufacturing facility. It manufactures nutritional products for a significant number of customers. On March 6, 2024, the Company entered into a sale and leaseback agreement relating to BSNM as more fully described under Note 5.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 1, 2021, SMFL acquired Doctors Scientific Organica, LLC d/b/a Smart for Life, Oyster Management Services, Ltd., Lawee Enterprises, L.L.C. and U.S. Medical Care Holdings, L.L.C. On August 27, 2021, SMFL transferred all of the equity interests of Oyster Management Services, Ltd., Lawee Enterprises, L.L.C. and U.S. Medical Care Holdings, L.L.C. to Doctors Scientific Organica, LLC. On May 19, 2022, SMFL acquired Lavi Enterprises, LLC. On the same date, SMFL transferred all of the equity interests of Lavi Enterprises, LLC to Doctors Scientific Organica, LLC. On December 13, 2022, Oyster Management Services, Ltd. was converted to a limited liability company known as Oyster Management Services, L.L.C. As a result of the foregoing, Oyster Management Services, L.L.C., Lawee Enterprises, L.L.C., U.S. Medical Care Holdings, L.L.C. and Lavi Enterprises, LLC are now wholly owned subsidiaries of Doctors Scientific Organica, LLC (collectively, “DSO”). Based in Riviera Beach, Florida, DSO operates a 30,000 square-foot FDA-certified manufacturing facility. DSO manufactures and sells weight management foods and related products. Additionally, DSO provides manufacturing services for other customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 24, 2021, Smart for Life Canada Inc. (“DSO Canada”) was established as a wholly owned subsidiary of Doctors Scientific Organica, LLC in Canada. SMFL Canada sells retail products through a retail store location in Montreal Canada and the same location also acts as distribution center for international direct to consumer and big box customers. It maintains inventory and employees at this location.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 8, 2021, SMFL acquired Nexus Offers, Inc. (“Nexus”). Nexus is a network platform in the affiliate marketing space. Affiliate marketing is an advertising model in which a product vendor compensates third-party digital marketers to generate traffic or leads for the product vendor’s products and services. The third-party digital marketers are referred to as affiliates, and the commission fee incentivizes them to find ways to promote the products being sold by the product vendor. Based in Miami, Florida, Nexus operates virtually.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2021, SMFL acquired GSP Nutrition Inc. (“GSP”). GSP is a sports nutrition company that offers nutritional supplements for athletes and active lifestyle consumers. Based in Miami, Florida, GSP operates virtually.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 29, 2022, SMFL acquired Ceautamed Worldwide, LLC and its wholly-owned subsidiaries Wellness Watchers Global, LLC and Greens First Female LLC (collectively, “Ceautamed”). Ceautamed is based in Boca Raton, Florida and owns the Greens First line of branded products which have been specifically marketed to the healthcare provider sector. On January 29, 2024, the Company entered into an asset purchase agreement pursuant to which the Company agreed to sell nearly all of the assets of Ceautamed and its subsidiaries for a 49% ownership interest in a new limited liability company. The agreement allows for the 51% owner to purchase the remaining 49% for $1 at an unspecified future date. See Note 16.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 15, 2022, SMFL entered into a joint venture with a seller of Ceautamed to form Smart Acquisition Group, LLC. This company was formed to expand M&A growth initiatives through the identification, negotiation, financing and acquisition of companies by SMFL.</p>
CY2019Q4	smfl	Percentage Of Acquired Agreement PercentageOfAcquiredAgreement	0.49	pure
CY2020Q4	us-gaap	Area Of Land AreaOfLand	22000	sqm
CY2022Q4	us-gaap	Area Of Land AreaOfLand	30000	sqm
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4464100	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55555556	shares
CY2023	smfl	Working Capital WorkingCapital	19700000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67700000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22700000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5800000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. These estimates include, among other items, assessing the collectability of receivables, the realization of deferred taxes, useful lives and recoverability of tangible and intangible assets, assumptions used in the valuation of options and warrants, incremental borrowing rate on lease liability, valuation of inventory, impairment of long lived assets, and accruals for commitments and contingencies. Some of these estimates can be subjective and complex and, consequently, actual results could differ materially from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	57581	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2897737	usd
CY2023Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	342531	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	1898384	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	1308748	usd
CY2023	us-gaap	Revenues Revenues	8225792	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2022	us-gaap	Revenues Revenues	15902529	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	675426	usd
CY2023	smfl	Contract With Customer Liability Deposits Received ContractWithCustomerLiabilityDepositsReceived	465263	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-675968	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	464721	usd
CY2023	smfl	Freight Costs Amount FreightCostsAmount	256249	usd
CY2022	smfl	Freight Costs Amount FreightCostsAmount	889493	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1580248	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2173594	usd
CY2023	smfl	Employee Retention Credits EmployeeRetentionCredits	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Employee Retention Credits</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), the Company filed for Employee Retention Credits for applicable periods in 2020 and 2021. As amounts to be refunded are subject to IRS calculations, and the timing for processing of the credits are unknown, the Company recognizes as other income amounts refunded upon the receipt of the payment. During the years ended December 31, 2023 and 2022, the Company received $586,556 and $0, respectively.</p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	217318	shares
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	279575	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	67075	usd
CY2023	smfl	Aggregate Purchase Price AggregatePurchasePrice	8600000	usd
CY2023	smfl	Purchase Price Consists Description PurchasePriceConsistsDescription	The purchase price consists of (i) $3,000,000 in cash, of which $1,000,000 was previously paid by the Company and $2,000,000 was paid at closing, (ii) secured subordinated convertible promissory notes in the aggregate principal amount of $2,150,000; (iii) secured subordinated promissory notes in the aggregate principal amount of $2,150,000 and (iv) secured subordinated promissory notes in the aggregate principal amount of $1,300,000.
CY2023Q4	us-gaap	Cash Cash	3000000	usd
CY2023	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1300000	usd
CY2023Q4	us-gaap	Cash Cash	3000000	usd
CY2023Q4	smfl	Debt Issued DebtIssued	5600000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	8600000	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	635223	usd
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	392529	usd
CY2023Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	8357306	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	8600000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	7930000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	19596961	usd
CY2022	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-29742915	usd
CY2022	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-3045.56
CY2022	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	9766	shares
CY2023	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-328846	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-213391	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	700340	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	732369	usd
CY2023	smfl	Disposal Group Including Discontinued Operations Compensation DisposalGroupIncludingDiscontinuedOperationsCompensation	296893	usd
CY2022	smfl	Disposal Group Including Discontinued Operations Compensation DisposalGroupIncludingDiscontinuedOperationsCompensation	529380	usd
CY2023	smfl	Disposal Group Including Discontinued Operation Professional Services DisposalGroupIncludingDiscontinuedOperationProfessionalServices	17073	usd
CY2022	smfl	Disposal Group Including Discontinued Operation Professional Services DisposalGroupIncludingDiscontinuedOperationProfessionalServices	4869	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	119776	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	153175	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	245899	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1287257	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1512517	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1616103	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1725908	usd
CY2023	smfl	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	194721	usd
CY2022	smfl	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	-8425	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	136983	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	229095	usd
CY2023	smfl	Disposal Group Including Discontinued Operation Gain On Debt Extinguishment DisposalGroupIncludingDiscontinuedOperationGainOnDebtExtinguishment	3230	usd
CY2022	smfl	Disposal Group Including Discontinued Operation Gain On Debt Extinguishment DisposalGroupIncludingDiscontinuedOperationGainOnDebtExtinguishment	168013	usd
CY2023	smfl	Disposal Group Including Discontinued Operation Total Otherexpense DisposalGroupIncludingDiscontinuedOperationTotalOtherexpense	-60968	usd
CY2022	smfl	Disposal Group Including Discontinued Operation Total Otherexpense DisposalGroupIncludingDiscontinuedOperationTotalOtherexpense	69507	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1555135	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1795415	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1555135	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1795415	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	252322	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	361623	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	617388	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	946884	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	373067	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	873844	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	1242777	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	2182351	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1242777	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2182351	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	471865	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	400907	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	371326	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	181716	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100539	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	219191	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	118595	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	112878	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	70958	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	70958	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3045000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5816100	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14040196	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18404220	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2993429	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2117122	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11046767	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16287098	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4134000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	340100	usd
CY2023	smfl	Impairment Expense impairmentExpense	5843501	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2154693	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1841948	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4750590	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	836332	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	836238	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	836238	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	813261	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2974108	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11046767	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	246140	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M2D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	534475	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	550309	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	566648	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	550920	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	437474	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	199302	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2839128	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	740326	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Product Liability Net LossContingencyAccrualProductLiabilityNet	2098802	usd
CY2023Q4	smfl	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	298644	usd
CY2023Q4	smfl	Noncurrents Portion Of Lease Liabilities NoncurrentsPortionOfLeaseLiabilities	1800158	usd
CY2023	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.15	pure
CY2023Q4	us-gaap	Additional Liability Long Duration Insurance Original Discount Rate Before Cash Flow And Reinsurance AdditionalLiabilityLongDurationInsuranceOriginalDiscountRateBeforeCashFlowAndReinsurance	788830	usd
CY2023	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	4475269	usd
CY2023Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.175	pure
CY2023	smfl	Gross Proceeds GrossProceeds	20000000	usd
CY2023Q2	smfl	Agreements Totaling Amount AgreementsTotalingAmount	276471	usd
CY2023Q4	us-gaap	Fair Value Option Ineligible Items Aggregate Carrying Amount FairValueOptionIneligibleItemsAggregateCarryingAmount	1347060	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	22500	usd
CY2023	smfl	Investor Shares InvestorShares	80	usd
CY2023Q2	smfl	Additional Payment AdditionalPayment	45141.05	usd
CY2023Q3	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	2155	shares
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	50000	usd
CY2023	smfl	Percentage Of Consideration PercentageOfConsideration	0.047	pure
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	77218	usd
CY2023Q4	us-gaap	Debtor In Possession Financing Amount Arranged DebtorInPossessionFinancingAmountArranged	50000	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	150000	usd
CY2023Q2	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	1400000	usd
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	334950	usd
CY2022Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2022Q3	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.10	pure
CY2023Q4	smfl	Aggregate Principal Amounts AggregatePrincipalAmounts	350000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	0	usd
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	200000	usd
CY2023Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.12	pure
CY2023Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.12	pure
CY2023Q4	us-gaap	Other Borrowings OtherBorrowings	43000	usd
CY2023Q3	smfl	Loan Agreement LoanAgreement	113000	usd
CY2023Q3	smfl	Repayment Loan Percenage RepaymentLoanPercenage	0.17	pure
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	103657	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	12630784	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-265984	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12364800	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	10757040	usd
CY2023Q4	us-gaap	Deferred Finance Costs Current Gross DeferredFinanceCostsCurrentGross	140926	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10616114	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1873744	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	125058	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1748686	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	19835728	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2885527	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5873881	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1266191	usd
CY2023	smfl	Noncash Debt Issued NoncashDebtIssued	295462	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6264000	usd
CY2023	smfl	Net Cash Advance Activity NetCashAdvanceActivity	154689	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	243395	usd
CY2023	smfl	Conversion Of Interest To Debt ConversionOfInterestToDebt	334950	usd
CY2023	smfl	Conversion Of Notes Payable To Accued Expenses ConversionOfNotesPayableToAccuedExpenses	26471	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	12364800	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	10616114	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	336627	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	460397	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	460397	usd
CY2023Q4	us-gaap	Time Deposit Maturities After Year Five TimeDepositMaturitiesAfterYearFive	385126	usd
CY2023Q4	us-gaap	Time Deposits Noncurrent TimeDepositsNoncurrent	106139	usd
CY2023Q4	us-gaap	Time Deposits TimeDeposits	12364800	usd
CY2023	us-gaap	Dividends Cash DividendsCash	0	usd
CY2022	us-gaap	Dividends Cash DividendsCash	0	usd
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1200000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	19000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14285091	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14285091	usd
CY2023	smfl	Deferred Tax Asset Taxable Net Loss DeferredTaxAssetTaxableNetLoss	16832240	usd
CY2023	smfl	Deferred Tax Assets Impairment Of Intangible Asset DeferredTaxAssetsImpairmentOfIntangibleAsset	5843501	usd
CY2023	smfl	Deferred Tax Assets Taxable Benefit DeferredTaxAssetsTaxableBenefit	22675741	usd
CY2023	smfl	Deferred Tax Asset Tax Rate DeferredTaxAssetTaxRate	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	19046997	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19046997	usd
CY2023	smfl	Net Operating Loss Tax Asset NetOperatingLossTaxAsset	17819862	usd
CY2022	smfl	Net Operating Loss Tax Asset NetOperatingLossTaxAsset	14285091	usd
CY2023	smfl	Impairment Of Intangible Asset Tax Asset ImpairmentOfIntangibleAssetTaxAsset	1227135	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19046997	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14285091	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19046997	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14285091	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4762000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2023	smfl	Tax Expenes TaxExpenes	0	usd
CY2022	smfl	Tax Expenes TaxExpenes	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61825000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	45000000	usd
CY2023Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1000
CY2021Q4	smfl	Temporary Equity Dividend Rate TemporaryEquityDividendRate	0.15	pure
CY2022Q4	smfl	Temporary Equity Dividend Rate TemporaryEquityDividendRate	0.24	pure
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	450562	usd
CY2023	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	2100.105
CY2023Q4	smfl	Preferred Stock Designated Shares PreferredStockDesignatedShares	1000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	8579	shares
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	457	shares
CY2022Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	14404128	usd
CY2022Q1	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	12738288	usd
CY2022Q1	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	13	shares
CY2022Q1	smfl	Aggregate Principal Amount AggregatePrincipalAmount	2250000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	292500	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	407	shares
CY2022Q4	smfl	Aggregate Shares AggregateShares	500	shares
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1000000	usd
CY2022Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	90000	usd
CY2022Q4	smfl	Net Proceeds Amount NetProceedsAmount	910000	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	30500	usd
CY2022Q4	smfl	Trading Price Per Share TradingPricePerShare	1102.5	shares
CY2023Q2	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	79	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1000	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1502	shares
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0063
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4454	shares
CY2023Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	194.04
CY2023Q2	smfl	Total Gross Proceeds TotalGrossProceeds	899326	usd
CY2023Q2	smfl	Net Proceeds Amount NetProceedsAmount	776933	usd
CY2023	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	334	shares
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	252.39375
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3270	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	6014	shares
CY2023Q2	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	0.0063
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	9284	shares
CY2023Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1585057	usd
CY2023Q2	smfl	Net Proceeds Amount NetProceedsAmount	1374367	usd
CY2023	us-gaap	Management And Service Fees Incentive Rate ManagementAndServiceFeesIncentiveRate	0.01	pure
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense	60000	usd
CY2023Q2	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	79	shares
CY2023Q3	smfl	Additional Share Of Common Stock AdditionalShareOfCommonStock	2155	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000	shares
CY2023	smfl	Exercise Of Warrants Shares ExerciseOfWarrantsShares	243222	shares
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7269531	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q3	smfl	Aggregate Shares AggregateShares	22024	shares
CY2023Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	23.31
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2023Q3	smfl	Aggregate Shares AggregateShares	20714	shares
CY2023Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	20.79
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2023	smfl	Compensation Expense CompensationExpense	797535	usd
CY2022	smfl	Compensation Expense CompensationExpense	53676	usd
CY2023	smfl	Percentage Of Cash Fee PercentageOfCashFee	0.075	pure
CY2023	smfl	Percentage Of Management Fee PercentageOfManagementFee	0.01	pure
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	4185	shares
CY2023Q4	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	12.39
CY2023Q4	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1552292	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	250572	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.64
CY2023Q4	smfl	Percentage Of Cash Fee PercentageOfCashFee	0.075	pure
CY2023Q4	smfl	Percentage Of Management Fee PercentageOfManagementFee	0.01	pure
CY2023Q4	smfl	Purchase Aggregate Shares PurchaseAggregateShares	9398	shares
CY2023Q4	smfl	Exercise Price ExercisePrice	15.4875
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	243222	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	457	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	32.06
CY2023	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	11.55
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M20D
CY2023	smfl	Stock Options Granted StockOptionsGranted	42736	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	127787	shares
CY2022	smfl	Stock Options Granted StockOptionsGranted	422	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.029	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.53	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	0	usd
CY2022	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	0	usd
CY2022Q3	us-gaap	Notes Issued1 NotesIssued1	2272727	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	6000	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.05	pure
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2200000	usd
CY2022Q3	smfl	Percentage Of Amendment PercentageOfAmendment	0.05	pure
CY2023	smfl	Annual Interest Rate Percentage AnnualInterestRatePercentage	0.20	pure
CY2023Q4	smfl	Gross Proceeds Percentage GrossProceedsPercentage	0.075	pure
CY2023	smfl	Percentage Of Management Fee PercentageOfManagementFee	0.01	pure
CY2023	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	458473	usd
CY2023Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	15318716	usd
CY2023	smfl	Designated Shares DesignatedShares	200000	shares
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	7
CY2023	smfl	Percentage Of Number Of Shares Of Common Stock Outstanding PercentageOfNumberOfSharesOfCommonStockOutstanding	0.0499	pure
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1527	shares
CY2023	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	105670	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	977.98	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	54367	shares
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Other Expenses OtherExpenses		usd
CY2022	smfl	Stock Issued During Period Value Common Stock Issued Upon Conversion Of Preferred Stock StockIssuedDuringPeriodValueCommonStockIssuedUponConversionOfPreferredStock		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	smfl	Noncash Operating Lease Costs NoncashOperatingLeaseCosts		usd
CY2022	smfl	Noncash Finance Fees NoncashFinanceFees		usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
CY2023	smfl	Interest Expense Associated With Warrants Issued With Debt InterestExpenseAssociatedWithWarrantsIssuedWithDebt		usd
CY2023	smfl	Interest Expense Associated With Future Equity Agreements InterestExpenseAssociatedWithFutureEquityAgreements		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	smfl	Stock Issued For Conversion Of Accounts Payable StockIssuedForConversionOfAccountsPayable		usd
CY2022	smfl	Stock Issued For Conversion Of Accrued Dividends StockIssuedForConversionOfAccruedDividends		usd
CY2022	smfl	Stock Issued For Conversion Of Series B Preferred Stock To Common Stock StockIssuedForConversionOfSeriesBPreferredStockToCommonStock		usd
CY2023	smfl	Noncash Equipment Financing Of Discontinued Operations NoncashEquipmentFinancingOfDiscontinuedOperations		usd
CY2023	smfl	Debt Issued In Connection With Acquisition Of Ceautamed DebtIssuedInConnectionWithAcquisitionOfCeautamed		usd
CY2023	smfl	Debt Issuance Cost In Connection With Debt DebtIssuanceCostInConnectionWithDebt		usd
CY2022	smfl	Equipment Transferred From Discontinued Operation EquipmentTransferredFromDiscontinuedOperation		usd
CY2022	smfl	Conversion Of Accrued Compensation ConversionOfAccruedCompensation		usd
CY2022	smfl	Stock Issued For Conversion Of Accrued Board Fees StockIssuedForConversionOfAccruedBoardFees		usd
CY2022	smfl	Conversion Of Notes Payable To Accued Expenses ConversionOfNotesPayableToAccuedExpenses		usd
CY2022	smfl	Conversion Of Interest To Notes Payable ConversionOfInterestToNotesPayable		usd
CY2022	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-3045.56
CY2022	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	9766	shares
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	smfl	Impairment Of Intangible Asset Tax Asset ImpairmentOfIntangibleAssetTaxAsset		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001851860

Files In Submission

Name	View Source	Status
0001213900-24-080709-index-headers.html	Edgar Link	pending
0001213900-24-080709-index.html	Edgar Link	pending
0001213900-24-080709.txt	Edgar Link	pending
0001213900-24-080709-xbrl.zip	Edgar Link	pending
ea0203858-10k_smart.htm	Edgar Link	pending
ea020385801ex10-11_smart.htm	Edgar Link	pending
ea020385801ex10-12_smart.htm	Edgar Link	pending
ea020385801ex10-13_smart.htm	Edgar Link	pending
ea020385801ex10-14_smart.htm	Edgar Link	pending
ea020385801ex10-47_smart.htm	Edgar Link	pending
ea020385801ex21-1_smart.htm	Edgar Link	pending
ea020385801ex23-1_smart.htm	Edgar Link	pending
ea020385801ex3-5_smart.htm	Edgar Link	pending
ea020385801ex31-1_smart.htm	Edgar Link	pending
ea020385801ex31-2_smart.htm	Edgar Link	pending
ea020385801ex32-1_smart.htm	Edgar Link	pending
ea020385801ex32-2_smart.htm	Edgar Link	pending
ea020385801ex4-1_smart.htm	Edgar Link	pending
ea020385801ex97-1_smart.htm	Edgar Link	pending
ex10-13_001.jpg	Edgar Link	pending
ex10-13_002.jpg	Edgar Link	pending
ex10-13_003.jpg	Edgar Link	pending
ex10-13_004.jpg	Edgar Link	pending
ex10-13_005.jpg	Edgar Link	pending
ex10-13_006.jpg	Edgar Link	pending
ex10-13_007.jpg	Edgar Link	pending
ex10-13_008.jpg	Edgar Link	pending
ex10-13_009.jpg	Edgar Link	pending
ex10-13_010.jpg	Edgar Link	pending
ex10-13_011.jpg	Edgar Link	pending
ex10-13_012.jpg	Edgar Link	pending
ex10-13_013.jpg	Edgar Link	pending
ex10-14_001.jpg	Edgar Link	pending
ex10-14_002.jpg	Edgar Link	pending
ex10-14_003.jpg	Edgar Link	pending
ex10-14_004.jpg	Edgar Link	pending
ex10-14_005.jpg	Edgar Link	pending
ex10-14_006.jpg	Edgar Link	pending
ex10-14_007.jpg	Edgar Link	pending
ex10-14_008.jpg	Edgar Link	pending
ex10-14_009.jpg	Edgar Link	pending
ex10-14_010.jpg	Edgar Link	pending
ex10-47_001.jpg	Edgar Link	pending
ex3-5_001.jpg	Edgar Link	pending
ex3-5_002.jpg	Edgar Link	pending
ex3-5_003.jpg	Edgar Link	pending
ea0203858-10k_smart_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
smfl-20231231.xsd	Edgar Link	pending
smfl-20231231_cal.xml	Edgar Link	unprocessable
smfl-20231231_lab.xml	Edgar Link	unprocessable
smfl-20231231_def.xml	Edgar Link	unprocessable
smfl-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

SMART FOR LIFE, INC.

2024 Q3 Form 10-K Financial Statement

#000121390024080709 Filed on September 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission